SCHEMBL5801133

SCHEMBL5801133

NC(=O)C(c1ccccc1Cl)N(C(N)=O)c1ccc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 9/20 0.39
MDM4 O15151 2/20 0.39
OPRM1 P35372 2/20 0.38
OPRL1 P41146 2/20 0.38
TSHR P16473 3/20 0.37
HIF1A Q16665 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NR1I2 O75469 1/20 0.37
ABCB11 O95342 1/20 0.37
LMNA P02545 1/20 0.37
NR3C1 P04150 1/20 0.37
PGR P06401 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADRA2A P08913 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
MAPT P10636 1/20 0.37
CNR1 P21554 1/20 0.37
SLC6A2 P23975 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3563022 0.90 MDM2 (0.41) MDM2MDM4OPRM1OPRL1TSHR
SCHEMBL5803975 0.86 MDM2 (0.34) MDM2MDM4LMNAMAPTL3MBTL1
SCHEMBL5801209 0.82 TRPM8 (0.47) MDM2KDM4ENR1I2MAPTALDH1A1
SCHEMBL3569300 0.76 CNR2 (0.41) MDM2MDM4MAPTALDH1A1CES2
SCHEMBL3564244 0.76 CES2 (0.36) MDM2MDM4MAPTATML3MBTL1
SCHEMBL3557436 0.76 PPARG (0.38) MDM2LMNAMAPTCNR1ALDH1A1
SCHEMBL3563412 0.76 PPARA (0.38) MDM2MDM4MAPTATMALDH1A1
SCHEMBL3568466 0.76 TRPM8 (0.41) MDM2TSHRCYP2C9CYP2C19KDM4E
SCHEMBL18901157 0.74 NISCH (0.50) OPRM1SLC6A2SLC6A4ALDH1A1CXCL8
SCHEMBL3566188 0.74 ATM (0.45) TSHRCYP2C9CYP2C19KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006063113-A2 UREAS AS FACTOR XA INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2006-06-15 WO claimed